Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2006, p. 2750-2759, Vol. 44, No. 8
0095-1137/06/$08.00+0 doi:10.1128/JCM.00112-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Division of Infectious Diseases,1 Division of Oncology, University Children's Hospital of Zurich, Zurich,2 Division of Oncology, University Children's Hospital of Bern,3 Institute of Infectious Diseases, University of Bern, Bern,4 Bio-Analytica AG, Lucerne, Switzerland5
Received 18 January 2006/ Returned for modification 6 May 2006/ Accepted 9 June 2006
|
|
|---|
102 CFU in water per reaction. DNA extraction protocols I and II, using less enzyme treatment, combined with other primer pairs giving shorter amplicons of 466 bp and 342 or 346 bp, respectively, were slightly more sensitive for the detection of gram-negative but less sensitive for the detection of gram-positive bacteria. The obstacle of detecting background DNA in blood samples spiked with bacteria was circumvented by introducing a broad-range hybridization probe, and this preserved the minimal detection limits observed in samples devoid of blood. Finally, sequencing of the amplicons generated using the primer pair Bak11W/Bak2 allowed species identification of the detected bacterial DNA. Thus, broad-spectrum PCR targeting the 16S rRNA gene in the quantitative real-time format can achieve an analytical sensitivity of 1 to 10 CFU per reaction in water, avoid detection of background DNA with the introduction of a broad-range probe, and generate amplicons that allow species identification of the detected bacterial DNA by sequencing. These prerequisites are important for its application to blood-containing patient samples. |
|
|---|
Microscopy, although rapid, requires a relatively large concentration of bacteria (
104 CFU/ml) to become positive (3), and identification based on morphology is often not possible. Furthermore, application of microscopy to blood samples is cumbersome, insensitive, and therefore not part of routine diagnostics. Culture results may be available only after 24 h to 72 h. Moreover, culture results may be false negative when fastidious or culture-resistant bacteria are involved or when patient samples are obtained after antimicrobial therapy has started. In these situations, broad-range PCR could offer an important benefit, as it can detect any kind of bacterial DNA present in a sample through targeting conserved bacterial sequences. In addition, sequencing of the amplicon generated by broad-range PCR allows subsequent identification of the organism, as the PCR product contains variable bacterial species-specific sequences. These sequences can be identified by comparison with known sequences deposited at GenBank or other databases (6, 25). Prerequisites for sufficient analytical sensitivity and specificity are (i) protocols for efficient extraction of bacterial genomic DNA, (ii) primer pairs designed to amplify bacterial DNA as broadly as possible and to generate amplicons sufficiently long for bacterial identification, and (iii) a probe avoiding detection of background DNA known to be present in some samples, e.g., blood (20).
Several broad-range PCR assays have been reported in the literature. The majority of these assays use primers targeting the 16S rRNA gene (6, 8, 10, 12, 13, 15, 17, 22-24), and a minority use primers targeting the 23S rRNA gene (7, 14, 22). Since broad-range PCR is more vulnerable to contamination than species-specific PCR (16), its adaptation to a real-time PCR-based format that does not require removal of samples from closed containers for sample transfer, reagent addition, or gel separation could offer advantages in this respect. Furthermore, real-time PCR allows quantification of the bacterial load. Until now, broad-range real-time PCR assays have rarely been devised to identify bacterial DNA detected in clinical samples (12).
The aims of the present study using real-time PCR-based assays were (i) to determine the lower detection limits of different bacterial genomic DNA extraction protocols followed by amplification of 16S rRNA gene sequences whereby different broad-range primer pairs detecting a panel of 22 bacterial species are used, (ii) to evaluate if the assays are applicable to blood samples spiked with bacteria, and (iii) to investigate whether identification of detected bacterial DNA by sequencing of the amplicons generated by real-time PCR using probes is feasible.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains used for this study
|
DNA extraction and purification. In order to compare their efficiencies, three different genomic DNA extraction and purification protocols were applied to the bacterial strains tested. For all three extraction methods, we started the extraction procedure from the same amount of bacterial pellet, i.e., the pellet of 1 ml of bacterial cell suspension with a McFarland standard of 0.5 as described above.
DNA extraction protocol I. DNA extraction protocol I was described earlier (8). In brief, a QIAmp DNA blood mini kit (QIAGEN, Basel, Switzerland) was used to extract bacterial DNA, with the following modifications to the instructions of the manufacturer. The bacterial pellet was resuspended in 200 µl digestion buffer (50 mM Tris HCl, pH 8.5, 1 mM EDTA, 0.5% sodium dodecyl sulfate). The mixture was incubated at 55°C for 1 h after addition of proteinase K (19.2 mg/ml; Roche, Mannheim, Germany) to a final concentration of 0.4 mg/ml. The final elution volume was 100 µl. For each PCR analysis, we used 1 µl of this DNA extract.
DNA extraction protocol II. For DNA extraction protocol II, bacterial pellets were initially resuspended with 20 µl TES buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 100 mM NaCl) and 5 U lysozyme (Ready Lyse; Epicenter, Madison, Wis.) and incubated for 12 h at room temperature. Then, protocol I was applied. The final elution volume was 100 µl. For each PCR analysis, we used 1 µl of this DNA extract.
DNA extraction protocol III. For DNA extraction protocol III, a Wizard SV genomic DNA purification system (Promega, Madison, Wis.) from the protocol Promega eNotes was used with the following modifications. The bacterial pellet was resuspended in 400 µl enzymatic lysis solution (47 mM EDTA, 25 mg/ml lysozyme [Sigma, St. Louis, Mo.], 20 µg/ml lysostaphin [Sigma]) and incubated at 37°C for 2 h. Then, proteinase K (19.2 mg/ml; Roche, Mannheim, Germany) was added to a final concentration of 0.4 mg/ml and the mixture was incubated at 55°C for 1 h. Nuclei Lysis solution (Promega) and RNase solution (Promega) were added, and after being mixed, the reaction solution was incubated at 80°C for 10 min. Further purification steps were done according to the instructions of the manufacturer. The final elution volume was 200 µl. For each PCR analysis, we used 2 µl of this DNA extract.
Design of primer pairs and probe. The sequences of the complete genome or of the 16S rRNA gene of all 22 bacterial species listed above were retrieved from GenBank. Three broad-range primer pairs targeting the 16S rRNA gene reported in the literature (8, 10, 17, 19) (Table 2) were validated using Clone Manager Suite 7 software (Scientific & Educational Software, Cary, North Carolina). The published broad-range probe Tap (24) (Table 2) was originally designed to be used with the primer pair Taf/Tar, but it was confirmed in GenBank that the Tap sequence also lies within the amplicon defined by the primer pair Bak11W/Bak2.
|
View this table: [in a new window] |
TABLE 2. Oligonucleotide primers and TaqMan fluorescent probe sequences used for real-time PCR assays
|
|
View this table: [in a new window] |
TABLE 3. Numbers of cycles and temperature settings for PCR
|
Sensitivity, detection range, and specificity. To determine the detection range, we prepared a 10-fold dilution series from 108 CFU/ml to 100 CFU/ml. The arbitrary definition for a detectable concentration was a cycle threshold (CT) value of 3 CT values lower than the mean CT value from the negative template control. This definition was chosen to have at least a 10-fold-higher concentration of detectable DNA in the positive samples than in the negative template control samples.
Sequencing. A BigDye Terminator v1.1 cycle sequencing kit (Applied Biosystems, Foster City, Calif.) was used to sequence the amplification products from S. aureus and E. coli generated following DNA extraction protocol III and PCR using the primer pair Bak11W/Bak2. Cycle sequencing (96°C for 1 min, followed by 30 cycles of 96°C for 10 s, 50°C for 5 s, and 60°C for 4 min) was performed with either Bak11W or Bak2. Sequencing products were purified by manual sodium acetate-ethanol precipitation. Following resuspension in 20 µl LAL reagent water (Cambrex), the samples were analyzed with an ABI Prism 310 genetic analyzer (PerkinElmer, Boston, Mass.).
Bacterial identification. Database analysis was done in a two-step procedure as described previously (1). A first search was performed with the FASTA algorithm of the GCG Wisconsin software package (Accelrys). All positions showing differences from the best scoring reference sequence were visually inspected in the electropherogram, and the sequence was corrected if necessary. Then, a second search was done using BLAST (http://www.ncbi.nlm.nih.gov/BLAST). Undetermined nucleotides in the determined sequence or the reference sequence were counted as matches. For each sequence, only the highest-scoring and, if applicable, the next-highest-scoring species were recorded.
|
|
|---|
103 CFU per PCR (Fig. 1A) and E. coli at concentrations of
102 CFU per PCR (Fig. 1B). Since the efficiency of DNA extraction from bacterial cells is one major determinant of the sensitivity of assays designed to detect bacterial DNA, we conducted a series of experiments aimed at an improvement of the extraction procedure, i.e., DNA extraction protocols II and III (see Materials and Methods) were used. Extraction protocol II resulted in no improvement in the sensitivity to detect S. aureus (Fig. 1C) or E. coli (Fig. 1D). By contrast, extraction protocol III allowed the detection of S. aureus and E. coli at concentrations as low as 101 CFU per PCR (Fig. 1E and F). These results suggested that extraction protocol III was superior to extraction protocols I and II in disrupting the bacterial cell wall, especially of gram-positive bacteria, allowing release of bacterial DNA and at the same time not significantly reducing its detection.
![]() View larger version (18K): [in a new window] |
FIG. 1. Comparison of analytical sensitivities of the broad-spectrum real-time PCR assays in water using primer pair Bak11W/Bak2 following extraction of genomic DNA using three different extraction protocols. (A and B) Extraction protocol I. (C and D) Extraction protocol II. (E and F) Extraction protocol III. (A, C, and E) Detection of S. aureus. (B, D, and F) Detection of E. coli. Results shown are the means and standard deviations of three independent experiments. SYBR green was included in the PCR mix to allow for detection of amplicons. The dashed lines are drawn at the CT of the negative control minus 3 CT values, defining the lower limit of detection.
|
![]() View larger version (17K): [in a new window] |
FIG. 2. Comparison of analytical sensitivities of the broad-spectrum real-time PCR assays in water using three different primer pairs following extraction of genomic DNA by protocol III. Results shown are the means and standard deviations of three independent experiments. SYBR green was included in the PCR mix to allow for detection of amplicons. The dashed lines are drawn at the CT of the negative control of a given primer pair minus 3 CT values, defining the lower limit of detection of this primer pair.
|
102 CFU per PCR, following extraction protocol II in detection of 16 (73%) strains, and following extraction protocol III in detection of 18 (82%) strains. By contrast, the use of the primer pair Taf/Tar resulted in the detection of 10 (46%), 16 (73%), and 6 (27.3%) of the 22 strains following their extraction at concentrations of
102 CFU per PCR using DNA extraction protocols I, II, and III, respectively. The primer pair 16SFa/16SFb/16SR detected one (5%), two (9%), and none (0%) of the 22 tested bacterial strains at concentrations of
102 CFU per PCR when using DNA extraction protocols I, II, and III, respectively. Whereas DNA extraction protocol III proved to be somewhat superior than DNA extraction protocols I and II for the detection of gram-positive bacteria, DNA extraction protocols I and II were superior than DNA extraction protocol III for the detection of gram-negative bacteria at concentrations of
102 CFU per PCR when using the primer pair Bak11W/Bak2. Nevertheless, DNA extraction protocol III followed by PCR using the primer pair Bak11W/Bak2 showed the best overall sensitivity for bacteria at concentrations of
102 CFU per PCR (Table 4). Thus, we used DNA extraction protocol III and the primer pair Bak11W/Bak2 in the subsequent experiments. |
View this table: [in a new window] |
TABLE 4. Synopsis of analytical sensitivities of the real-time broad-range PCR assays in relation to primer pairs and extraction protocols used
|
102 per PCR, and final detection using SYBR green. The results were compared with the results obtained using LAL water instead of blood. As shown in Fig. 3, PCR targeting 16S rRNA in blood samples not experimentally mixed with bacteria resulted in positive signals at around 13 CT values below the CT values obtained for LAL reagent water not mixed with bacteria (27 versus 40). PCR with whole-blood samples mixed with S. aureus or E. coli showed CT values that were similar for all bacterial concentrations of
104 CFU per PCR and interpreted as negative, i.e., less than 3 U below the negative control. These results indicated that, when the concentration of the bacteria introduced into the blood samples was reduced below a certain level, broad-spectrum PCR detected nonspecific DNA sequences interfering with detection of DNA sequences from the bacteria introduced. In consequence, the analytical sensitivity of the assay applied to blood samples was diminished by at least 2 to 3 orders of magnitude. The presence of background DNA in blood has been reported previously (20). To exclude external bacterial contamination in the negative blood controls, we sequenced the amplification products obtained in these samples. The nucleotide sequences did not match with any known bacterial sequence or with human DNA (data not shown).
![]() View larger version (10K): [in a new window] |
FIG. 3. Analytical detection ranges and sensitivities of the broad-spectrum real-time PCR assays using the primer pair Bak11W/Bak2 following DNA extraction protocol III from blood samples spiked with bacteria. SYBR green was used for detection. (A) Detection of S. aureus. (B) Detection of E. coli. Results shown are the means and standard deviations of three independent experiments.
|
40 (Fig. 4). This indicated that the probe did not detect amplified background DNA in blood samples. Furthermore, the CT values for S. aureus and E. coli, respectively, were similar in whole blood and saline for bacterial concentrations of >10 CFU per PCR (Fig. 4). Thus, the introduction of the TaqMan probe prevented the detection of background DNA and maintained the sensitivity of the assay.
![]() View larger version (10K): [in a new window] |
FIG. 4. Analytical detection ranges and sensitivities of the broad-spectrum real-time PCR assays using the primer pair Bak11W/Bak2 following DNA extraction protocol III from blood samples spiked with bacteria. A TaqMan probe was used for detection. (A) Detection of S. aureus. (B) Detection of E. coli. Results shown are the means and standard deviations of three independent experiments.
|
91% sequence agreement was found at concentrations of
103 CFU per PCR, at least with one of the two sequencing primers, and for E. coli, >90% agreement at concentrations of
10 CFU per PCR (Table 5). |
View this table: [in a new window] |
TABLE 5. Sequencing of amplicons from templates with different concentrations and similarities to the template species
|
|
|
|---|
The minimal detection limits of our broad-range real-time PCR assays following DNA extraction protocols that used different amounts of enzymes varied between 10 and 106 CFU per PCR for the bacterial species investigated. The extraction protocol III described here, which uses lysozyme, lysostaphin, and proteinase K, combined with PCR using the primer pair Bak11W/Bak2 and resulting in amplicons of 796 bp in length showed the best overall analytical sensitivity for the detection of bacteria in water at concentrations of
102 per PCR, with a >80% detection rate. For selected bacterial species, including the gram-positive species Bacillus cereus, Corynebacterium diphtheriae, Staphylococcus epidermidis, Streptococcus milleri, and Streptococcus pneumoniae and the gram-negative species E. coli and Klebsiella oxytoca, the minimal detection limit was as low as 1 CFU per PCR. Thus, the primer set resulting in the longest amplicons was overall the most sensitive. This may seem counterintuitive as shorter amplicons should amplify more efficiently than the longe amplicon. Shorter amplicons, however, showed lower CT values than the longest amplicons when negative template samples were tested and thus reduced the analytical sensitivity. Nevertheless, depending on the bacterial species, the use of DNA extraction protocol I or II in combination with the same or other primer pairs in too many instances yielded lower minimal detection limits than extraction protocol III combined with the primer pair Bak11W/Bak2. This was especially the case for gram-negative species. These results suggest that the combination of DNA extraction protocol and primer pair determines analytical sensitivity. Indeed, currently there seems to be no DNA extraction protocol that has the same effectiveness for both gram-positive and gram-negative bacteria. Most studies of broad-spectrum PCR assays have reported the use of commercial kits, enzyme treatment, freezing and thawing or boiling, mechanical disruption, or a combination of these methods (7, 10, 12, 13, 17, 19, 24, 26) for DNA extraction. Minimal detection limits were determined only for S. aureus or E. coli or both and were in the range between 10 and 103 CFU or CFU equivalents per PCR (7, 10, 12, 13, 17, 19, 24, 26). Thus, the minimal detection limit of our assays for these two bacterial species was among the lowest reported so far. Our results further highlight the fact that the combinations of bacterial DNA extraction protocols and primer pairs are differently suited for detection of different bacterial species. This needs to be taken into account when evaluating the analytical sensitivities of broad-range PCR assays and calls for the determination of minimal limits of sensitivity for a panel of bacterial species. Nevertheless, the performance of the assays presented here needs to be studied with clinical samples before the assays can be introduced into routine diagnostics.
The introduction of a broad-range probe targeting a highly conserved sequence within the sequence amplified by the broad-range primer pairs prevented the detection of background DNA in blood samples spiked with bacteria and protected the sensitivity of the assay when applied to bacteria diluted in saline. The application of broad-range PCR to blood specimens has yielded results suggesting the presence of bacterial DNA in healthy individuals (20). Recently, the use of a broad-range probe proved to be extremely useful in avoiding the detection of background DNA (19, 26). The fluorescein-tagged probe Tap used in this study was originally described for the primer pair Taf/Tar (19). We confirmed by a GenBank evaluation that this probe had a position inside amplicons from the primer pair Bak11W/Bak2. Yang et al. reported an elegant innovation, i.e., the combination of broad-range primer pairs with a broad-range probe and a species-specific probe that circumvents nonspecific DNA detection while conserving the sensitivity and the specificity of the assay (26). At present, this system is limited by the number of fluorophores commercially available and the discriminatory power of the detection instruments. Therefore, such a multiprobe real-time PCR assay can at present be designed only for a very restricted number of bacterial species.
A major observation of this study was that a primer pair generating amplicons of more than 500 bp could be used in a real-time PCR format. The amplification products of 804 bp for S. aureus and 797 bp for E. coli generated by the primer pair Bak11W/Bak2 allowed identification of the bacterial species present in the sample by sequencing. Species identification by sequencing required at least 10 to 103 bacterial CFU in the original PCR sample (Table 5), which was 1 to 2 orders of magnitude higher than the analytical sensitivity of the assay per reaction in water. It should be noted that Shigella shares a very high DNA homology with E. coli and should be included in the same species (18). Further, species differentiation within Enterobacteriaceae based on sequencing is generally difficult due to high sequence homologies (18). In this context, it needs to be stressed that the maximum length of determined sequences was 540 bp. Thus, since sequencing was performed from both ends the sequenced portions were not identical. This explains why, depending on the sequencing direction, the sequences did not match. Nevertheless, the assay reported here represents a remarkable step towards improvement of the identification of the bacterial culprit when using broad-range real-time PCR assays. This is of considerable clinical interest given the limited possibilities mentioned in designing a multiprobe real-time PCR.
In this study we made no attempts to decontaminate PCR materials but used highly purified reagents such as AmpliTaq Gold and LAL reagent water. Broad-range PCR assays are more vulnerable to contamination than species-specific PCRs. Taq DNA polymerases are frequently reported as an important source of contaminating bacterial DNA (2, 4). In agarose gel electrophoresis detection systems, several approaches, including UV irradiation, 8-methoxypsoralen treatment, DNase treatment, and restriction endonuclease treatment, have successfully overcome this problem (11). However, most decontamination procedures also affect the sensitivity of a broad-range PCR when a sensitive detection system, such as TaqMan, is used (5). One exception to this is the pre-PCR ultrafiltration step recently described by Yang et al. (26). In our assays, the negative template control showed CT values between 38 and 40, suggesting the absence of contaminating eubacterial DNA in that control. This and our arbitrary definition of detectable bacterial DNA concentration set at 3 CT values below the CT value of the negative template control, i.e., detection of DNA only when present at least at concentrations 10-fold higher than that in the negative control, did not induce us to perform an ultrafiltration of the PCR master mix. Nevertheless, we used the purified AmpliTaq Gold DNA polymerase (26). The omission of decontamination methods might be risky in a clinical or research laboratory.
In conclusion, the DNA extraction protocol III presented here combined with the broad-range primer pair Bak11W/Bak2 plus the Tap probe validated in a real-time PCR format is suitable for the detection and quantification of bacteria not only in otherwise-sterile body fluids but also in blood samples and in addition allows for bacterial speciation of the detected DNA by sequencing. The time required from start to finish of the 16S RNA detection is 8 to 9 h, and the time required for sequencing is 3 to 4 h. Thus, results can be obtained within 1 to 2 working days. Therefore, the quantitative broad-range PCR assay reported here not only may serve as a tool for an improved etiological diagnosis, for pathogenetic studies, and for monitoring of invasive bacterial infections but also may be used to identify bacterial contamination of blood products.
This study was in part supported by a grant from AstraZeneca, Switzerland.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»